Highstreet Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.77M Buy
27,325
+18,085
+196% +$1.18M 0.08% 100
2019
Q3
$586K Buy
9,240
+3,022
+49% +$198K 0.03% 187
2019
Q2
$420K Sell
6,218
-8,480
-58% -$558K 0.02% 215
2019
Q1
$956K Sell
14,698
-25,203
-63% -$1.68M 0.05% 143
2018
Q4
$2.5M Sell
39,901
-12,089
-23% -$845K 0.16% 76
2018
Q3
$4.01M Buy
51,990
+3,234
+7% +$244K 0.22% 60
2018
Q2
$3.45M Buy
48,756
+5,621
+13% +$397K 0.21% 59
2018
Q1
$3.25M Buy
43,135
+6,744
+19% +$536K 0.21% 57
2017
Q4
$2.61M Buy
36,391
+10,359
+40% +$787K 0.15% 71
2017
Q3
$2.11M Buy
26,032
+9,188
+55% +$703K 0.2% 62
2017
Q2
$1.19M Buy
+16,844
New +$1.12M 0.13% 97
2017
Q1
Sell
-10,423
Closed -$746K 160
2016
Q4
$746K Sell
10,423
-7,308
-41% -$543K 0.26% 100
2016
Q3
$1.4M Buy
17,731
+7,793
+78% +$633K 0.48% 59
2016
Q2
$829K Buy
+9,938
New +$882K 0.29% 85
2016
Q1
Sell
-49,100
Closed -$4.97M 171
2015
Q4
$4.97M Buy
+49,100
New +$5.11M 1.06% 35
2015
Q2
Sell
-11,306
Closed -$1.11M 149
2015
Q1
$1.11M Sell
11,306
-1,200
-10% -$122K 0.33% 92
2014
Q4
$1.18M Buy
12,506
+3,107
+33% +$321K 0.29% 93
2014
Q3
$1M Sell
9,399
-7,959
-46% -$779K 0.22% 109
2014
Q2
$1.44M Sell
17,358
-8,327
-32% -$648K 0.31% 100
2014
Q1
$1.82M Buy
+25,685
New +$2.01M 0.4% 68

Other funds holding GILD

Highstreet Asset Management's GILD Position: Q4 2019 in Review

Highstreet Asset Management increased its Gilead Sciences (GILD) stake by 196% in Q4 2019, buying an estimated $1.18M and bringing the position to 27,325 shares worth $1.77M. The position accounts for 0.08% of the portfolio, ranked #100.

Highstreet Asset Management first reported a position in GILD in Q1 2014 and has held it in 20 quarters since. The position peaked at $4.97M in Q4 2015. 1,556 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Highstreet Asset Management held 27,325 shares of Gilead Sciences worth $1.77M as of Q4 2019.
  • Highstreet Asset Management bought 18,085 Gilead Sciences shares in Q4 2019, an estimated $1.18M.
  • Gilead Sciences made up 0.08% of Highstreet Asset Management's portfolio in Q4 2019, its #100 holding.
  • Highstreet Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 20 quarters since.
  • Highstreet Asset Management's Gilead Sciences position peaked at $4.97M in Q4 2015.
  • 1,556 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.